https://knews.kathimerini.com.cy/en/news/cyprus-records-strong-cancer-survival-outcomes-across-major-cancer-types
Cancer patients in Cyprus are achieving survival outcomes that surpass the European Union average for several of the most common forms of the disease, according to figures presented during a press conference held by biopharmaceutical company Bristol Myers Squibb....
https://knews.kathimerini.com.cy/en/news/new-two-minute-cancer-jab-could-replace-hours-long-hospital-treatments
Thousands of cancer patients across England are set to spend far less time in hospital thanks to a new injectable form of immunotherapy that can be given in as little as one or two minutes instead of through lengthy IV drips....
https://knews.kathimerini.com.cy/en/news/cypriot-researchers-develop-new-strategy-to-break-through-aggressive-tumors
The breakthrough comes from the Institute’s Department of Genetic, Therapeutic and Ultrastructural Pathology of Cancer, led by Professor Dr. Fotios Bekris. ...
https://knews.kathimerini.com.cy/en/news/hio-under-fire-for-denying-critical-cancer-and-chronic-disease-treatments
A growing controversy has emerged in Cyprus after reports that the Health Insurance Organization (HIO) has denied access to several vital medications and therapies for patients with cancer, autoimmune diseases, and other serious chronic conditions....
https://knews.kathimerini.com.cy/en/news/groundbreaking-cancer-study-by-cyprus-institute-of-neurology-and-genetics
Researchers from CING have published a new study in Cancers, offering significant insights for the accurate staging and early detection of multiple myeloma....
https://knews.kathimerini.com.cy/en/news/over-50-of-advanced-melanoma-patients-survive-10-years
A groundbreaking trial has shown that more than half of patients diagnosed with advanced melanoma now survive at least 10 years when treated with a combination of two immunotherapy drugs....
https://knews.kathimerini.com.cy/en/news/new-vaccine-shows-promise-against-deadly-skin-cancer
In a groundbreaking development in cancer treatment, doctors are conducting trials on what could be the world’s first personalized mRNA vaccine against melanoma, marking a potential game-changer in the fight against cancer....
https://knews.kathimerini.com.cy/en/news/revolutionary-mrna-vaccine-boosts-skin-cancer-treatment-by-65
In a mid-stage trial, Moderna Inc and Merck & Co announced on Monday that the addition of their experimental mRNA-based vaccine has shown a 65% reduction in the risk of spreading the deadliest form of skin cancer when used in combination with immunotherapy alone....
https://knews.kathimerini.com.cy/en/business/nipd-genetics-a-medicover-company-announces-the-addition-of-six-new-neothetis-liquid-biopsy-tests-for-therapy-selection
NIPD Genetics announces the addition of six new NeoThetis liquid biopsy tests for therapy selection, which include Breast & Gynecological, Gastric, Melanoma, Pancreatic, Prostate and Pan-Cancer. ...
https://knews.kathimerini.com.cy/en/news/new-cancer-killing-virus-injected-into-human-patient-for-the-first-time
Scientists have injected the first human patient with a new cancer-killing virus. The virus, known as Vaxinia, has seen successful tests in animals. However, the true test of its efficacy begins with this new clinical trial....
https://knews.kathimerini.com.cy/en/business/nipd-genetics-announces-new-foresentia-panel-to-include-tumor-mutational-burden-biomarker
NIPD Genetics announces the launch of a new ForeSENTIA tumor profile panel, Pan-Cancer Plus, which includes the analysis of the genomic biomarker Tumor Mutational Burden (TMB). ...
https://knews.kathimerini.com.cy/en/news/new-cancer-therapy-completely-destroys-advanced-ovarian-and-colorectal-tumors-in-6-days
A new cancer therapy has completely destroyed advanced ovarian and bowel tumors in just six days....
